Director Global Strategic Planning - Digital Transformation, Sandoz International

Location: Holzkirchen, Germany
Job Type: Full-Time
Employer: Sandoz (Novartis Group)
Sandoz is currently recruiting for a Director Global Strategic Planning - Digital Transformation to join our Global Strategic Team to lead large-scale, global strategic initiatives to drive significant business improvement in digital area.

The purpose of the Director Global Strategic Planning role is to Manage multiple, cross-functional project teams ensuring rapid results generation of assigned initiatives.

Key Responsibilities

  • Set the digital aspiration for Sandoz and translate that into a tangible roadmap for the next 3-5 years and beyond
  • Closely collaborate with all Novartis divisions to identify synergies and opportunities along digital agenda and solutions
  • Drive the implementation across functions and geographies in Sandoz and track the success
  • Work with key stakeholders in top management to enable their “digital readiness” and informed decision making
  • Build and coordinate a small capable team to develop solutions on how we innovate, sell and operate
  • Act as the crystallization point for all digital topics of strategic value between Sandoz and external world, i.e.,
  • Respond to or identify business challenges within Sandoz which could be resolved by digital solutions and coordinate the solution
  • Identify new business models in the market (products and services) that may be a model for Sandoz and push their adoption in the division
  • Actively identify and start collaborations with external parties (e.g., startups) which can also be exploratory in nature
  • Help initiatives and colleagues (individually or in groups) to become more digital, more agile and more customer-centric

Minimum requirements

  • Significant experience at top tier consultancy (with relevant CXO interaction)
  • Proven experience as project manager is a must-have, ideally
  • First-hand experience in developing and delivering digital strategies/transformations along e.g,. multi-channel, web-enabled design, big data analytics, cloud computing, e-commerce etc.
  • Highly desired: Demonstrable track-record in building digital businesses, particularly as a founder
  • Savviness in innovative digital trends, e.g. IoT, Blockchain, Artificial Intelligence, Neural Networks etc
  • Top academic achievements
  • Fluency in English & at least 1 additional European language
  • Tested capability to successfully lead teams and projects, often with tight time constraints
  • Entrepreneurial spirit with Can-do, pro-active attitude
  • Excellent communication and presentation skills

Apply for this job

About Sandoz
Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people’s lives. We contribute to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our portfolio of approximately 1000 molecules, covering all major therapeutic areas, accounted for 2016 sales of USD 10.1 billion. In 2016, our products reached well over 500 million patients and we aspire to reach one billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.

Sandoz Biopharmaceuticals, a global business unit of Sandoz, comprises biosimilars, contract manufacturing and Glatopa 20mg (glatiramer acetate). It is a USD one billion business (2016 annual sales). As the pioneer and global leader in biosimilars, with sales in 86 countries and five marketed biosimilars in Europe, Sandoz is committed to increasing patient access to high-quality, life-enhancing biosimilars. Its biosimilar products (Omnitrope, Binocrit, Zarzio/Zarzio, Rixathon and Erelzi) have generated more than 340 million patient days of experience. Sandoz has a leading biosimilar pipeline and plans to launch a total of five biosimilars of major oncology and immunology biologics across major markets between 2017 and 2020. A division of the Novartis Group, Sandoz is well-positioned to continue leading the biosimilars industry based on its experience and capabilities in development, manufacturing, and commercialization.

Post your job offer now to start hiring the best digital health talent! For further information, please contact us.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

The Human Touch of Doctors will Still be…

AI-based medicine will revolutionise care including for Alzheimer’s and diabetes, predicts a technology expert, but it must be accessible to all patients. Healing with Artificial Intelligence, written by technology expert Daniele...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...

Brain Imaging may Identify Patients Like…

By understanding differences in how people’s brains are wired, clinicians may be able to predict who would benefit from a self-guided anxiety care app, according to a new analysis from...

Stepping for Digital Rewards

Walking is well known to have significant health benefits, but few people achieve the daily recommended steps. Fortunately, mobile health (mHealth) applications have emerged as promising tools to promote physical...